TIRVA ROBERT L. (Interim CFO) sold 3.1% of their position (10.36K shares) of DNA X, INC. on the open market
Open‑market sale worth $5.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/22/2022ACC: 0000899243-22-023558
-10.36K
Net shares
Net seller
$5.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.36K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.36K
Price / share
$0.54
Trade value
$5.59K
% of position
3.1%
6/21/2022
334.88K→324.52K
Total
Net shares
−10.36K
Net value
-$5.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/21/2022 | S · Sale | −10.36K | $0.54 | $5.59K | 3.1% | 334.88K | 324.52K |
| Total | −10.36K | -$5.59K | ||||||
Derivative Transactions0
No derivative transactions reported